These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 8890725

  • 1. Role of progesterone deficiency in the development of luteinizing hormone and androgen abnormalities in polycystic ovary syndrome.
    Fiad TM, Cunningham SK, McKenna TJ.
    Eur J Endocrinol; 1996 Sep; 135(3):335-9. PubMed ID: 8890725
    [Abstract] [Full Text] [Related]

  • 2. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
    Berga SL, Yen SS.
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
    [Abstract] [Full Text] [Related]

  • 3. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
    Lewandowski KC, Cajdler-Łuba A, Salata I, Bieńkiewicz M, Lewiński A.
    Endokrynol Pol; 2011 Feb; 62(2):120-8. PubMed ID: 21528473
    [Abstract] [Full Text] [Related]

  • 4. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, Marshall JC.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [Abstract] [Full Text] [Related]

  • 5. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
    Lewandowski KC, Cajdler-Luba A, Bieńkiewicz M, Lewiński A.
    Neuro Endocrinol Lett; 2011 Nov; 32(6):847-56. PubMed ID: 22286802
    [Abstract] [Full Text] [Related]

  • 6. Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.
    Cheung AP, Lu JK, Chang RJ.
    Hum Reprod; 1997 Jun; 12(6):1156-64. PubMed ID: 9221993
    [Abstract] [Full Text] [Related]

  • 7. Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome.
    Venturoli S, Porcu E, Fabbri R, Magrini O, Gammi L, Paradisi R, Forcacci M, Bolzani R, Flamigni C.
    Clin Endocrinol (Oxf); 1988 Jan; 28(1):93-107. PubMed ID: 3139335
    [Abstract] [Full Text] [Related]

  • 8. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C, Sciarra F.
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [Abstract] [Full Text] [Related]

  • 9. Which hormone tests for the diagnosis of polycystic ovary syndrome?
    Robinson S, Rodin DA, Deacon A, Wheeler MJ, Clayton RN.
    Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
    [Abstract] [Full Text] [Related]

  • 10. Effect of bromocriptine on LH pulsatility in the polycystic ovary syndrome.
    Chapman AJ, Wilson MD, Obhrai M, Sawers RS, Lynch SS, Royston JP, Clayton RN.
    Clin Endocrinol (Oxf); 1987 Nov; 27(5):571-80. PubMed ID: 3450455
    [Abstract] [Full Text] [Related]

  • 11. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.
    Patel K, Coffler MS, Dahan MH, Malcom PJ, Deutsch R, Chang RJ.
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):67-74. PubMed ID: 14678290
    [Abstract] [Full Text] [Related]

  • 12. Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate.
    Armstrong VL, Wiggam MI, Ennis CN, Sheridan B, Traub AI, Atkinson AB, Bell PM.
    QJM; 2001 Jan; 94(1):31-7. PubMed ID: 11161134
    [Abstract] [Full Text] [Related]

  • 13. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
    Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE.
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302
    [Abstract] [Full Text] [Related]

  • 14. The gonadotropic axis in hyperandrogenic adolescents.
    Taylor AE.
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 5():1281-4. PubMed ID: 11117670
    [Abstract] [Full Text] [Related]

  • 15. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
    Ye BL, Yang HY, Zhao JZ, Lin JJ, Lin WQ.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846
    [Abstract] [Full Text] [Related]

  • 16. Augmented frequency and mass of LH discharged per burst are accompanied by marked disorderliness of LH secretion in adolescents with polycystic ovary syndrome.
    García-Rudaz MC, Ropelato MG, Escobar ME, Veldhuis JD, Barontini M.
    Eur J Endocrinol; 1998 Dec; 139(6):621-30. PubMed ID: 9916868
    [Abstract] [Full Text] [Related]

  • 17. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
    McCartney CR, Eagleson CA, Marshall JC.
    Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
    [Abstract] [Full Text] [Related]

  • 18. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M, Liz-Lestón J, Lado-Abeal J.
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.